The amino terminal sequence of the Candida albicans cell wall protein Int1 exhibited partial identity with the major histocompatibility complex (MHC) class II binding site of the Mycoplasma arthritidis superantigen MAM. Int1-positive C. albicans blastospores activated human T lymphocytes and expanded V␤ subsets 2, 3, and/or 14; Int1-negative strains were inactive. Release of interferon-␥ (IFN-␥) but not of tumor necrosis factor-␣ or interleukin-6 was Int1 dependent; interleukin-4 and interleukin-10 were not detected. T lymphocyte activation, V␤ expansion, and IFN-␥ release were associated with a soluble polypeptide that encompassed the first 263 amino acids of Int1 (Pep 263 ). Monoclonal antibody 163.5, which recognizes an Int1 epitope that overlaps the region of identity with MAM, significantly inhibited these activities when triggered by Int1-positive blastospores or Pep 263 but not by staphylococcal enterotoxin B. Histidine 263 was required. Pep 263 bound to T lymphocytes and MHC class II and was detected in the urine of a patient with C. albicans fungemia. These studies identify a candidal protein that displays superantigen-like activities.
Candida species have emerged as the fourth most common cause of nosocomial bloodstream infections, and Candida albicans typically predominates [1] [2] [3] [4] . Although mucosal colonization is usually not a direct cause of mortality, entry of C. albicans into the bloodstream is associated with fatality rates of 10%-49% among patients with thermal burns, cardiopulmonary bypass or abdominal surgery, neutropenia or neutrophil dysfunction, or extreme prematurity (birth weight, Ͻ1000 g) [5] . Although most patients with candidemia have a prolonged course with an incremental cost of treatment ranging from $40,000 to $90,000 per patient [6, 7] , a few rapidly progress to hypotension and death accompanied by concentrations of proinflammatory cytokines (i.e., interferon-␥ [IFN-␥], tumor necrosis factor-␣ [TNF-␣], and interleukin-6 [IL -6] ) that exceed those found in bacterial infections [8 -10] .
With other opportunistic pathogens, such as Aspergillus fumigatus, a fulminantly fatal course may be facilitated by toxins, including aflatoxin or gliotoxin. Neither toxin has been identified in C. albicans [11] , although provocative evidence for a superantigen-like toxin derives from the observation that human peripheral blood mononuclear cells (PBMCs) incubated with C. albicans skin test antigen increased gene transcripts for V␤ subsets 5.1 and 5.2 [12] . The amino terminus of the C. albicans cell wall protein Int1 (relative molecular mass, 220 kDa), named for its integrinlike sequence and putative roles in adhesion, morphogenesis, and virulence [13, 14] , displays 56% identity with the major histocompatibility complex (MHC) class II binding site of the well-characterized superantigen MAM from Mycoplasma arthritidis [15] (figure 1). We therefore investigated the possibility of Int1-dependent superantigen activity in C. albicans.
MATERIALS AND METHODS

Strains.
C. albicans strains included CAF2 and its isogenic Int1-negative mutant CAG3 [14] , as well as a sec-ond Int1-negative mutant (VBIDM2) constructed with polymerase chain reaction (PCR)-mediated mutagenesis [16] and expressing only the first 21 amino acids of Int1 (table 1) .
PCR-mediated disruption of INT1. Materials and methods are specified in the appendix, which is only available in the electronic edition of the journal.
Antibodies. The following antibodies were obtained: antihuman CD3, CD4, CD8, CD25, CD69, HLA-DR/IgG2a, and secondary conjugates (Becton Dickinson); anti-human TCR V␤ subsets (Beckman Coulter); and IgG1 isotype control for monoclonal antibody (mAb) 163.5 (Becton Dickinson). Typically, 10 L were used to stain 10 6 cells. The immunizing peptide for mAb 163.5 (Inhibitex) was C-VNSEPEALTDMKLKRENFSNLSLDEKVNLY coupled to ovalbumin.
Activation of human PBMCs by C. albicans. Organisms were grown to saturation (optical density at 600 nm [OD 600 ] ϭ 0.5) in yeast extract/peptone/dextrose (YPD) medium with shaking at 30°C overnight; subcultures grown to early exponential phase in fresh YPD at 30°C (OD 600 ϭ 0.25) were washed twice in phosphate buffered saline (PBS) containing 0.2 g/mL of amphotericin B (Invitrogen) to eliminate filamentous growth of C. albicans [23, 24] . Preliminary experiments showed that this concentration of amphotericin B did not inhibit the response of PBMCs to staphylococcal enterotoxin B (SEB) or Int1-positive C. albicans.
Whole blood was collected from adult donors by venipuncture, using heparinized vacutainer tubes (Becton Dickinson). PBMCs were isolated by standard methods, using Histopaque (Sigma). PBMCs washed with Hanks balanced salt solution were resuspended at 2.5 ϫ 10 6 cells/mL in medium containing RPMI1640 supplemented with 2 mmol/L of L-glutamine, 100 U/mL of penicillin, 100 g/mL of streptomycin, 1 mmol/L of sodium pyruvate, 0.1 mmol/L of nonessential amino acids, 20 mmol/L of Hepes, 10% certified fetal bovine serum, and 0.2 g/mL of amphotericin B. In experiments with anti-HLA-DR antibodies, 10 g/mL of azide free anti-HLA-DR or mouse IgG2a isotype control was added to PBMCs prior to plating.
A total of 5 ϫ 10 5 blastospores in PBS were inoculated into each well of a 96-well plate and incubated at 37°C for 30 min. PBS manually aspirated from the culture wells containing adherent blastospores was replaced with 200 L of complete medium containing 5 ϫ 10 5 PBMCs, after ascertaining microscopically that wells contained approximately equal numbers of Int1-positive or Int1-negative yeast cells. SEB (Sigma; concentration, 10 -100 ng/mL) served as a control. Plates were incubated at 37°C in 5% CO 2 .
Flow cytometry. For all experiments except those with data reported in figure 2B, PBMCs were harvested for antibody staining on the fourth day of coculture and were analyzed by flow cytometry for expression of the specified marker. Fluorochrome-labeled antibodies and conjugates were used in 2-color, 3-color, or 4-color flow cytometry with a FACSCalibur (BD Biosciences). Data were analyzed with Win-MDI software, version 2.8 (available at: http://facs.scripps.edu/ software.html). Each experiment was performed in duplicate or triplicate wells; 30,000 cells from each well were analyzed.
Paraformaldehyde fixation of antigen-presenting cells and purification of T cells. PBMCs were plated in petri dishes at 37°C for 1 h. Adherent antigen-presenting cells were harvested by incubating cells at 4°C for 1 h in Ca 2ϩ -free and Mg 2ϩ -free PBS that contained 1 mmol/L EDTA and 0.5% glucose. T cells were purified from the nonadherent population to 95% purity, using a human T cell enrichment column kit (R&D Systems). PBSwashed antigen-presenting cells were resuspended in either complete medium or 0.06% paraformaldehyde (Sigma). After 5 min in paraformaldehyde at 37°C, ice cold 0.06% glycyl glycine was added (Sigma) [25] . After 2 PBS washes, paraformaldehydetreated antigen-presenting cells were incubated in complete medium (CM; 0.17% Difco yeast nitrogen base, 0.5% NH 4 SO 4 , 2% glucose, and 1.5% Bacto-agar) at 37°C for an additional 30 min to remove residual paraformaldehyde before resuspension in fresh medium. Purified T cells and antigen-presenting cells were combined at a ratio of 2. Int1-negative blastospores (VBIDM2) for 4 days at 37°C. In control incubations, Pep 263 or Int1-negative blastospores were omitted. All cells in each experimental mixture were washed with 1ϫ PBS/3% BSA/0.02% sodium azide (FACS buffer), pelleted by centrifugation at 500 g, and stained for 25 min at room temperature with 10 L of CD3-FITC (BD Pharmingen) and 10 L of a 1:10 dilution of streptavidin-phyco-erythrin (PE) (BD Pharmingen). In the absence of biotinylated Pep 263 , no binding of streptavidin-PE to T lymphocytes was observed.
Experiments to measure the binding of biotinylated Pep 263 to antigen-presenting cells were performed in the conditions described above, save that adherent antigen-presenting cells were Western immunoblotting. Five milliliters of urine from a 43-day old premature male of 24 weeks' gestation with C. albicans fungemia was centrifuged at 2500 g at 4°C for 10 min to remove cellular debris. Clarified urine was concentrated 50-fold on a Centricon Plus-20 5000-molecular weight-cutoff filter (Millipore) at 4000 g at 4°C for 30 min. Urine from 4 healthy adults was treated identically. Retentates from each sample were denatured under reducing conditions and electrophoresed on a 7.5% SDS-PAGE gel. As an additional control, recombinant Pep 263 was added to an aliquot from the retentate of 1 healthy donor. Proteins were transferred to a nitrocellulose membrane mouse IgG (GE Healthcare Bio-Science) at a dilution of 1:5000 in TBS-MT. After another wash with TBST, the membrane was developed with SuperSignal West Femto (Pierce) and exposed to Kodax Blue XB-1 film for 1 min.
Human subjects. Isolation of PBMCs from adults was approved by the Yale Human Investigations Committee (HIC #1047). Collection of urine from the infant received an exemption because the specimen would otherwise have been discarded.
Statistical analysis. Statistical comparisons were performed using an unpaired Student t test; a P value of Ͻ.05 was considered statistically significant.
RESULTS
Int1-dependent T cell activation, V␤ expansion, and IFN-␥ secretion induced by C. albicans blastospores.
Coculture of human PBMCs with Int1-positive C. albicans blastospores for 3.5 days induced an average of 15 foci of T cell blasts, each of which had a diameter of 5 m (figure 2A); Int1-negative mutants missing amino acids 434 -1664 [14, 17] or 21-1664 induced on average 1 foci of T cell blasts per well, which was equivalent to the induction rate in medium alone (figure 2A).
Unless otherwise stated, cells were harvested on the fourth day of coculture for analysis by flow cytometry. Both Int1-positive strains and their respective reintegrants activated T lymphocytes, as measured by up-regulation of the IL-2 receptor CD25; Int1-negative isogenic strains were significantly less active (P Ͻ .002). A mutant with 2 disrupted copies of EFG1 (which encodes a transcription factor linked to enhanced filamentous growth [18] ) was not impaired (figure 2B). The pattern was identical with a second activation marker, CD69 (figure 2B).
Populations (table 2) . In coculture with PBMCs from 5 adult donors, the Int1-positive strain was associated with up-regulation of the IL-2 receptor in all donors; isogenic Int1-negative mutants were inactive. These effects were statistically significant on days 4 -7 (P Ͻ .02) (figure 2C).
A monoclonal antibody against the HLA-DR ␣-subunit had no effect on T lymphocyte activation in response to phytohemagglutinin but partially inhibited T cell activation induced by toxic shock toxin (TSST-1) or by Int1-positive C. albicans blastospores (P Ͻ .04). Blockade of HLA-DR did not affect the negligible T cell response induced by isogenic Int1-negative mutants ( figure 2D ).
In the absence of antigen-presenting cells, neither SEB, the Int1-positive strain, or the isogenic Int1-negative mutant induced T cell activation (figure 2E). In the presence of adherent antigen-presenting cells, T lymphocytes were activated by SEB and the Int1-positive strain. Paraformaldehyde fixation of antigen-presenting cells did not inhibit T cell activation induced by SEB or by Int1-positive blastospores. Int1-negative blastospores were inactive under all conditions.
The expansion of T lymphocyte populations bearing specific V␤ subsets is a hallmark of superantigens, although there is considerable donor-to-donor variation in the combination of subsets expanded [26] . For example, SEB expands T lymphocytes expressing V␤ subsets 3, 12, 14, 15, 17, or 20 [26, 27] . We defined "expansion" as a response to Int1-positive cells that was 5 times the response to Int1-negative cells. All donors expanded V␤ subsets 2, 3, or 14 in Int1-dependent fashion (figure 3). One donor also expanded V␤7.1 ( figure 3 ). In no case did we observe expansion of V␤ subsets by Int1-negative cells. In 3 experiments involving a donor with expansion of V␤2 and V␤14 in response to Int1-positive C. albicans, a mean (ϮSD) of 80.0% Ϯ 6.6% cells expressing V␤2 and 77.8% Ϯ 6.7% expressing V␤14 also expressed CD25; in response to SEB, 79.3% Ϯ 6.4% of cells expressing V␤14 also expressed CD25. Thus, Ͼ75% of V␤2 and V␤14 T cells were activated in response to Int1-positive C. albicans. Expansion of V␤ subsets is accompanied by release of proinflammatory cytokines [28, 29] . C. albicans blastospores elicited TNF-␣, IL-6, and IFN-␥, with the latter cytokine elicited in an Int1-dependent fashion (table 3) ; neither IL-4 nor IL-10 was detected, which was consistent with observations reported elsewhere [30] . Staining for intracellular IFN-␥ showed that 97.1% of IFN-␥ was produced by CD25 ϩ cells in response to Int1-positive C. albicans, a result equivalent to what was observed with SEB. Characterization of a monoclonal antibody to the amino terminus of Int1. Linear peptides spanning amino acids 239 -278 of Int1 were used to generate murine mAb. Only mAb 163.5 recognized Pep 263 , a construct encompassing the first 263 amino acids of Int1 ( figure 4) . mAb 163.5 significantly inhibited activation of T lymphocytes (P Ͻ .035) (figure 5A) and expansion of V␤ subsets 2 (P Ͻ .02) and 14 (P Ͻ .02) (figure 5B) induced by Int1-positive C. albicans, compared with the activity of an irrelevant IgG1 control. Neither mAb 163.5 nor the isotype control inhibited T cell activation or expansion of the V␤14 subset triggered by SEB ( figure  5A and 5B). Therefore, mAb 163.5 was specific for Int1. 
Localization of superantigen-like activity to the amino terminus of Int1p. Because of the inhibitory effects of mAb 163.5, a construct encompassing the first 263 amino acids of Int1 (Pep 263 ) was expressed and purified. In the presence of Int1-negative blastospores, soluble Pep 263 was associated with blastogenic foci of T lymphocytes (data not shown), expansion of V␤ subsets 2 and 14, and release of IFN-␥ ( figure 5C and 5D ). mAb 163.5 significantly inhibited the expansion of V␤ subsets 2 (P ϭ .02) and 14 (P ϭ .01) and the release of IFN-␥ (P Ͻ .01) in response to Pep 263 ( figure 5C and 5D) , compared with the effects of an irrelevant IgG1 isotype control.
Structural requirements for the function of soluble Pep 263 . Mutation of key histidine residues in classical superantigens aborts their potency [31] [32] [33] figure 5C and 5D) . Control experiments determined that heat-killed Int1-negative blastospores or live Saccharomyces cerevisiae could not substitute for replicating Int1-negative blastospores (figure 6). We hypothesized that Int1-negative blastospores were required for the interaction of Pep 263 with T lymphocytes or antigen-presenting cells.
By FACS analysis, biotinylated Pep 263 bound to a mean (ϮSD) of 5.8% Ϯ 0.3% of CD3 ϩ T lymphocytes in the presence of Int1-negative blastospores but only to 1.2% Ϯ 0.5% of T lymphocytes in their absence. Pep 263 bound equivalently to CD4 
DISCUSSION
Superantigens elicit their effects by bridging the ␣ or ␤ subunit of the MHC class II locus and T lymphocytes bearing certain V␤ sequences at the T cell receptor [26, 34] . Although superantigens are not processed within the antigen-presenting cell or presented in the peptide groove, participation of MHC class II and costimulatory molecules such as B7-1 is required [35] . By obviating the mechanisms that control the well-modulated production of proinflammatory cytokines from antigen-specific T lymphocytes upon presentation of microbial antigens in the peptide groove, most bacterial superantigens recruit up to 10,000-fold more T lymphocytes of both CD4 ϩ and CD8 ϩ phenotypes, thereby triggering excessive release of cytokines such as IFN-␥, TNF-␣, or IL-6. Results reported here indicate that several effects associated with superantigens-activation of T lymphocytes independently of antigen processing and presentation, expansion of T cell populations expressing specific V␤ subsets, and elicitation of IFN-␥-are associated with a polypeptide (Pep 263 ) derived from the amino terminus of the C. albicans cell wall protein Int1. As with classic superantigens, such as TSST-1 or staphylococcal enterotoxin A, the C-terminal histidine residue of Pep 263 is essential for T lymphocyte activation and V␤ expansion [32, 33, 36] . Soluble Pep 263 binds to T lymphocytes and to MHC class II molecules; however, because Pep 263 requires the presence of Int1-negative blastospores for full activity, its effects might best be called "superantigen like."
These activities amplify the putative roles of Int1 in adhesion, morphogenesis, and virulence derived from earlier mutational analyses [13, 14] . Localization of Int1 to the septin ring at the junction of the mother-daughter dyad in budding yeast cells, a key marker for polarity [37] , may also provide a critical orientation that enables Pep 263 to enhance virulence. Although elegant Two separate lines of evidence formed the critical underpinnings for these studies. First, a surprising identity between the extensively characterized superantigen MAM and the amino terminus of Int1 (figure 1) is much stronger than the identity of MAM with other superantigens, such as SEB, SEC-1, mouse mammary tumor virus, and HIV-1 gp160 [15] .
Second, in vitro stimulation of human PBMCs with an extract prepared from boiled C. albicans blastospores led to a selective increase in gene transcripts for V␤ 5.1 and 5.2 [12] . Forty-eight hours after injection of a C. albicans filtrate into the skin, infiltrating T lymphocytes bearing V␤ 5.1 and 8.1 subsets were detected. As noted by Walsh et al. [12] , these results raised the tantalizing prospect of a C. albicans-derived superantigen-like moiety; however, the reactive species was not further characterized. There are at least 2 possible explanations for the differences between our results and those of Walsh et al. [12] . First, they used PCR for detection of V␤ transcripts, whereas we used flow cytometry to measure the binding of specific antibodies to expressed V␤ sequences. Second, they boiled their reagents, which may have significantly altered the predominant cell surface proteins of C. albicans. Expression of Pep 263 in S. cerevisiae and purification by affinity chromatography should be less damaging to glycosylation and native conformation.
Although Pep 263 induces T cell activation, specific V␤ expansion, and production of IFN-␥, the requirement for the Int1-negative mutant ( figure 5C and 5D) does not fit the paradigm of a bacterial superantigen. Because heat-killed Int1-negative blastospores and live S. cerevisiae are ineffective (figure 6), some C. albicans-dependent, active process must be involved. Our experiments have not ruled out a role for Int1-negative blastospores in modifying the amino terminus of Pep 263 or in contributing non-Int1-derived peptides to optimize its presentation, much as SEA 126 -131 peptides are required for optimal presentation of TSST-1 [41] . Mutant-induced proteolysis of the KLKH sequence at the carboxyl terminus of Pep 263 seems unlikely, because removal of H 263 nullifies activity. Interestingly, SEC-1, SEC-2, and SEC-3 have a KLKN sequence within the region that determines V␤ subset specificity [42] . Further experiments are underway to differentiate among these possibilities.
Although fulminant death from candidemia occurs in but a minority of patients, at least 2 potential clinical interventions are suggested by these studies. In addition to candidal mannans and ␤-glucans, which serve as potent elicitors of TNF-␣ [43, 44] , the production of IFN-␥ in response to Int1 and the possible contributions of Toll-like receptors, costimulatory molecules, and HLA alleles may permit modulation of the host response [38, 45] . In this regard, human immunodeficiency virus-infected subjects receiving recombinant IFN-␥ showed reduced candidal infections and improved 3-year survival in a phase III trial [46] . As a first step to therapeutic neutralization or augmentation, a case-control study correlating HLA-DR haplotype, IFN-␥ production, and outcome of candidemia could help to identify [28, 47] .
A humanized form of mAb 163.5 may also confer therapeutic benefits through its ability to modulate Int1-dependent T cell activation, V␤ expansion, and IFN-␥ production. The identification of a C. albicans protein responsible for superantigen-like effects and the development of a monoclonal antibody that inhibits these activities in vitro suggest potential strategies for risk assessment, prevention, and therapy of C. albicans bloodstream infection in susceptible populations. Table 4 shows the PCR primers used to amplify the DNA constructs for gene disruption. For gene disruption, PCR mixtures contained 1 mL of miniprep template DNA (pGEM-URA3 and pRS-ARG4⌬Spe1), 2 L of a 10-mmol/L solution of deoxynucleoside triphosphates, 2 mL of a 10-mmol/L stock of each (forward and reverse) primer, and 0.75 mL of a 100 mmol/L solution of MgSO 4 ; water was inserted until the mixture reached a volume of 50 mL, after which 0.5 mL of a 1 U/mL solution of Vent enzyme (New England BioLabs) was added. The PCR cycling conditions were as follows: 94°C for 5 min followed by 30 cycles of 94°C for 45 s, 50°C for 1 min and 72°C for 3 min with a final extension step of 72°C for 8 min. Strain BWP17 was grown to mid-exponential phase (ϳ0.5 at A 600 nm) in 50 mL YPD at 30°C. After collection by centrifugation, the cells were washed in 5 . The plates were supplemented with 50 mL of uridine at 50 g/mL in the first round of disruption, since the ARG4-mediated disruptions were done first. A rapid extraction protocol provided template DNA for verifying genotypes of resultant Arg-positive and Arg-positive/Urapositive colonies [20] . Genotyping PCRs confirmed INT1 gene disruptions in strain VBIDM2 (figure 9), using 1.5 mL of DNA with locus-specific detection primers (table 4) and the cycling conditions described earlier. The primer combination of INT1U, 5Det-INT1, and 3Det-INT1 was used to detect wildtype and disrupted INT1 alleles. Construction of NH 2 -tagged 6XHis-Pep 263 expression vector. pBluescript SK phagemid (Stratagene) was used to assemble the GAL1 promoter and the sequence coding for the first 263 amino acids of Int1 tagged with 6 histidines at either the amino or carboxy terminus, followed by the MAT␣ transcription termination sequence. Plasmid pCG01 [14] containing the GAL1:10 promoter and the entire INT1 open reading frame served as a template for PCR amplification with primers DDC11F and DDC11R to yield product PCR1. The GAL1 promotor flanked by a 5' EcoRI site and a 3' BamHI site followed by 13 base pairs of the INT1 5' untranslated region (UTR) ending in sequential SphI and HindIII sites was excised from PCR1 and cloned into pBSIISK as an EcoRI/HindIII fragment to generate pBS ⅐ PCR1. Primers DDC15F and DDC15R generated PCR2, which was cloned into the SphI/HindIII sites of pBS ⅐ PCR1 to generate pBS ⅐ PCR1,2, thereby placing the signal methionine codon followed by the 6XHIS-Pep 263 coding sequence and stop codon immediately downstream of the GAL1 promoter and 5' INT1 UTR.
APPENDIX SUPPLEMENTARY MATERIALS AND METHODS
PCR
The MAT␣ transcription termination sequence was PCR amplified from vector pYD1 (Invitrogen), using primers DDC13F and DDC1R. The HindIII/SalI fragment was cloned into pBS ⅐ PCR1,2 to yield pBS ⅐ PCR1,2,3. The sequence of the entire EcoRI/SalI insert was confirmed using T3 and T7 primers (HHMI/Keck Foundation Biotechnology Resource Laboratory).
Site-directed mutagenesis of Pep 263 codon 251. The CUG codon is translated as serine in Candida albicans and as leucine in S. cerevisiae [21, 22] . INT1 contains 6 CUG codons, one of which lies within the first 789 nucleotides of INT1. To correct for the difference in the product of the CUG codon between C. albicans and S. cerevisiae, 1 round of site-directed mutagenesis was performed using the Quickchange XL site-directed mutagenesis kit (Stratagene) to convert the C. albicans CTG serine codon at amino acid 251 to TCG, such that expression in S. cerevisiae substituted a serine residue for leucine at this position. Briefly, gel-purified mutagenesis primers DCMUT2F and DCMUT2R were used to PCR amplify pBS ⅐ PCR1,2,3, according to the manufacturer's instructions. The manufacturer's recommended temperatures were used for denaturation and annealing. After 18 cycles, 10 U of restriction enzyme DPN1 were added to the PCR reaction to digest the methylated template DNA. XL-10 Gold competent cells were transformed with digest. DNA preparations from ampicillin-resistant colonies were sequenced with T3 and T7 primers to confirm the codon change. Expression vector p6XH-Pep 263 was created by cloning the 1600-bp EcoRI/ Sal I fragment derived from pBS ⅐ PCR1,2,3 with TCG at codon 251 into Yep357 (ATCC 37732), a yeast shuttle vector containing the URA3 selectable marker and a 2-m replicon to maintain high copy number in S. cerevisiae.
Construction of COOH-tagged Pep 263 -6XHis expression vector. The 452-bp GAL1 promoter excised from pBS ⅐ PCR1,2,3 by EcoRI/ BamHI digestion was cloned into the corresponding restriction sites of Yep357. p6XH-Pep 263 served as template for PCR amplification of the 5' UTR of INT1 followed by the sequence encoding Pep 263 -6XHis, using primers DDC43F and DDC29R. The BamHI/Hind III digest of this PCR product along with the HindIII/SalI digest of the MAT␣ transcription termination PCR product were cloned into the BamHI/Sal I sites of pBSIISK. Sequence was confirmed using the T3 and T7 primers. This BamHI/SalI fragment was cloned into the corresponding restriction sites of Yep357 that contained the GAL1 promoter to yield expression vector pPep 263 -6XH.
Expression of Pep 263 -6XHis. Protease-deficient S. cerevisiae strain BJ3501 (table 3) was transformed with expression vector 
